您的位置: 首页 > 农业专利 > 详情页

TRAITEMENT DU CANCER AU MOYEN D'UN INHIBITEUR SMAD3
专利权人:
The Chinese University Of Hong Kong
发明人:
申请号:
EP19150641.9
公开号:
EP3527213A1
申请日:
2013.10.28
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present invention resides in the discovery that Smad3, a key downstream mediator of TGF-β signaling, plays a critical role in development and progression of cancer. Thus, this application provides for a novel method of treating cancer by inhibiting Smad3 signaling, such as through administration of SIS3, an inhibitor of Smad3. Further provided are compositions and kits useful for treating cancer by way of inhibiting Smad3 signaling.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充